It’s possible that the plasma of recovered COVID-19 patients may have antibodies that could help in the treatment of others with COVID-19.
Multisystem Inflammatory Syndrome in children (MIS-C) and COVID-19: What providers should know
A CHOC infectious disease specialist shares information about children and MIS-C, cases of which are rare but rising.
Rapid genome testing for infants saves lives, costs
A recently completed pilot program at CHOC and other California clinical sites helped target a baby’s specific genetic disease in just days.
CHOC hematologist appointed to national COVID-19 therapy evaluation oversight committee
A CHOC hematologist and prolific author on innovative medicine, Dr. Diane Nugent joins the executive committee of NHLBI’s CONNECTS.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
A physician shares his best tips for a successful telehealth practice
A pediatric ophthalmologist shares best practices that a variety of specialists can implement today when adding telehealth to their services.
